Inactive Instrument

InterMune Inc Stock

Equities

US45884X1037

Biotechnology & Medical Research

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2014	CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals	RE
2014	Roche : rules out mega deals, open to smaller ones - paper	RE

on all our subscriptions*

Take advantage of the offer

* See conditions on site

Latest news about InterMune Inc

CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals	14-09-16	RE
Roche : rules out mega deals, open to smaller ones - paper	14-09-04	RE
Biogen Idec : InterMune drug may offer big upside to Roche if aimed at liver	14-08-27	RE
Burger King Worldwide : S&P 500 sets record high but fails to hold 2,000 mark	14-08-25	RE
CHUGAI PHARMACEUTICAL : Roche to buy U.S. biotech firm InterMune for $8.3 billion	14-08-25	RE
Horizon Pharma Inc : With eye on tax rates, Horizon Pharma buys Ireland's Vidara	14-03-19	RE
NVIDIA Corporation : SAC insider-trading probe could last years	13-06-06	RE
Weight Watchers International, Inc. : SAC Capital up 4 percent this year as probe continues	13-03-20	RE
Morgan Stanley : Cohen's SAC to pay $616 million in SEC insider trade settlement	13-03-15	RE
InterMune, Inc. : Blackstone seen sticking with SAC despite insider trading probe	12-12-28	RE
Weight Watchers International, Inc. : SAC Capital's top consumer trader draws U.S. scrutiny	12-12-19	RE
Elan Corporation, plc : Exclusive: U.S. authorities probe SAC for Weight Watchers - sources	12-12-07	RE
InterMune, Inc. : InterMune posts lower-than-expected revenue	12-07-23	RE

Press releases InterMune Inc

InterMune : Announces Effective Date of Make Whole Fundamental Change and Offer to Purchase to Holders of 2.50% Senior Convertible Notes Due 2018	14-10-02	PU
InterMune : Announces Anticipated Fundamental Change for 5.00% Convertible Senior Notes Due 2015	14-09-05	PR
InterMune : Stockholders Encouraged to Contact Securities Law Firm about Takeover	14-08-27	PR
InterMune : Ryan & Maniskas, LLP : Announces Investigation of InterMune, Inc.	14-08-26	PR
InterMune : Newman Ferrara LLP : Announces Investigation of InterMune, Inc.	14-08-25	BU

More press releases

News in other languages on InterMune Inc

Wall Street finit dans le vert, le S&P passe un cap	14-08-25
Burger King Worldwide : Wall Street ouvre en hausse sur un nouveau record du S&P	14-08-25
Apple : USA-Les valeurs à suivre à Wall Street	14-08-25
CHUGAI PHARMACEUTICAL : Roche achète l'américain InterMune pour 8,3 milliards de dollars	14-08-25
Roche va racheter l'américain InterMune pour $8,3 mds	14-08-24

Managers and Directors - InterMune Inc

Managers	Title	Age	Since
Edward Harrington CEO	Chief Executive Officer	-	-
Marianne T. Armstrong CTO	Chief Tech/Sci/R&D Officer	69	02-03-31
Carla Fiankan LAW	General Counsel	-	11-07-31

Company Profile

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+22.56%	46.71B
IQVIA HOLDINGS INC.	-1.51%	41.52B
LONZA GROUP AG	+48.83%	41.8B
CELLTRION, INC.	-3.42%	29.55B
ICON PUBLIC LIMITED COMPANY	+10.13%	25.78B
ALNYLAM PHARMACEUTICALS, INC.	-20.44%	19.26B
MEDPACE HOLDINGS, INC.	+26.45%	11.98B
BIO-TECHNE CORPORATION	-0.14%	12.14B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.47%	12.08B

Other Biotechnology & Medical Research

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW